[go: up one dir, main page]

HK186396A - Benzo(5,6)cyclo-heptapyridines compositions and method of use - Google Patents

Benzo(5,6)cyclo-heptapyridines compositions and method of use

Info

Publication number
HK186396A
HK186396A HK186396A HK186396A HK186396A HK 186396 A HK186396 A HK 186396A HK 186396 A HK186396 A HK 186396A HK 186396 A HK186396 A HK 186396A HK 186396 A HK186396 A HK 186396A
Authority
HK
Hong Kong
Prior art keywords
benzo
heptapyridines
cyclo
compositions
cyclohepta
Prior art date
Application number
HK186396A
Other languages
English (en)
Inventor
John J Piwinski
Ashit K Ganguly
Michael J Green
Frank J Villani
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HK186396A publication Critical patent/HK186396A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK186396A 1986-10-31 1996-10-03 Benzo(5,6)cyclo-heptapyridines compositions and method of use HK186396A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/925,342 US4826853A (en) 1986-10-31 1986-10-31 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use

Publications (1)

Publication Number Publication Date
HK186396A true HK186396A (en) 1996-10-11

Family

ID=25451584

Family Applications (1)

Application Number Title Priority Date Filing Date
HK186396A HK186396A (en) 1986-10-31 1996-10-03 Benzo(5,6)cyclo-heptapyridines compositions and method of use

Country Status (22)

Country Link
US (1) US4826853A (fi)
EP (3) EP0685476A1 (fi)
JP (1) JPH0678316B2 (fi)
KR (1) KR930002489B1 (fi)
AT (1) ATE116310T1 (fi)
AU (1) AU604285B2 (fi)
CA (2) CA1305147C (fi)
CS (1) CS414391A3 (fi)
DE (1) DE3750929T2 (fi)
DK (1) DK73193A (fi)
ES (1) ES2068179T3 (fi)
FI (1) FI96768C (fi)
HK (1) HK186396A (fi)
IE (1) IE65174B1 (fi)
IL (1) IL84310A0 (fi)
MY (1) MY102986A (fi)
NZ (1) NZ222347A (fi)
OA (1) OA09546A (fi)
PH (1) PH26184A (fi)
SG (1) SG44597A1 (fi)
WO (1) WO1988003138A1 (fi)
ZA (1) ZA878128B (fi)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3007193A (en) * 1959-01-12 1961-11-07 Nat Glass Company Inc Adjustable hinge
US4804666A (en) * 1985-08-14 1989-02-14 Schering Corporation Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines
US5438062A (en) * 1986-10-31 1995-08-01 Schering Corporation Benzo(5,6)cycloheptapyridines, compositions and methods of use
US5665726A (en) * 1986-10-31 1997-09-09 Schering Corporation Benzo[5,6]cycloheptapyridines, compositions and methods of use
US5089496A (en) 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
CA1341370C (en) * 1988-04-28 2002-06-18 John J. Powinski Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents
EP0341860B1 (en) * 1988-04-28 1994-07-13 Schering Corporation Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use
US4863931A (en) * 1988-09-15 1989-09-05 Schering Corporation Antihistaminic fluoro substituted benzocycloheptapyridines
ES2012297A6 (es) * 1989-04-10 1990-03-01 Espnola De Especialidades Farm Procedimiento para la obtencion de nuevos derivados imidazolicos diclorados con actividad antifungica.
AU620996B2 (en) * 1989-07-04 1992-02-27 Hokuriku Pharmaceutical Co. Ltd. 4-{(dibenzocycloheptene) or (dibenzoxepin)}-1-substituted piperidines
IE68935B1 (en) * 1990-06-22 1996-07-24 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene piperidylidene and piperazine compounds compositions and methods of use
KR970005927B1 (ko) * 1990-10-10 1997-04-22 쉐링 코포레이션 디아릴메틸피페리딘 또는 피페라진의 피리딘 및 피리딘 n-옥사이드 유도체, 이를 함유하는 약제학적 조성물 및 이의 제조방법
JPH05506249A (ja) * 1990-10-10 1993-09-16 シェリング・コーポレーション ビスーベンゾシクロヘプタピペリジリデン、ピペリジンおよびピペラジン化合物、組成物および使用法
WO1992006981A1 (en) * 1990-10-10 1992-04-30 Schering Corporation Substituted imidazobenzazepines and imidazopyridoazepines
JPH0676403B2 (ja) * 1991-01-18 1994-09-28 エスエス製薬株式会社 新規なベンゾ[5,6 シクロヘプタ[1,2−b ピリジン誘導体及びこれを含有する抗アレルギー剤
EP0586560A1 (en) * 1991-05-23 1994-03-16 Schering Corporation Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use
EP0524784A1 (en) * 1991-07-23 1993-01-27 Schering Corporation Benzopyrido piperidylidene compounds as PAF antagonists
JP2974529B2 (ja) * 1992-02-20 1999-11-10 北陸製薬株式会社 両性型三環系化合物
DE69310904T2 (de) * 1992-03-27 1997-08-28 Schering Corp Verbrückte bis-aryl-carbinol-derivate, zusammensetzungen und ihre verwendung
AU3918993A (en) * 1992-03-27 1993-11-08 Schering Corporation Unbridged bis-aryl carbinol derivatives, compositions and methods of use
US5648360A (en) * 1992-05-19 1997-07-15 Schering Corporation Pentacyclic antihistamines
ES2042421B1 (es) * 1992-05-22 1994-08-01 Uriach & Cia Sa J Procedimiento para la obtencion de la 8-cloro-11-*1-*(5-metil-3-piridil)metil*-4-piperidiliden*-6,11-dihidro-5h-benzo*5,6*ciclohepta*1,2-b*piridina.
KR100346802B1 (ko) * 1993-07-13 2002-11-29 얀센 파마슈티카 엔.브이. 항앨러지성이미다조아제핀
US6365588B1 (en) 1993-10-15 2002-04-02 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5719148A (en) * 1993-10-15 1998-02-17 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
US5661152A (en) * 1993-10-15 1997-08-26 Schering Corporation Tricyclic sulfonamide compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5721236A (en) 1993-10-15 1998-02-24 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US6075025A (en) 1993-10-15 2000-06-13 Schering Corporation Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
DK0723538T3 (da) * 1993-10-15 2002-03-18 Schering Corp Tricykliske carbamatforbindelser, der er nyttige til inhibition af funktion af G-protein og til behandling af proliferative sygdomme
ES2087818B1 (es) * 1993-11-24 1997-03-16 Uriach & Cia Sa J 8-cloro-11-(1-((5-metil-3-piridil)metil)-4-piperidiliden)-6,11-dihidro-5h-benzo-(5,6)cicloheptal(1,2-b)piridina, fumarato.
US5538986A (en) * 1993-12-06 1996-07-23 Schering Corporation Tricyclic derivatives, compositions and methods of use
US5574173A (en) * 1993-12-06 1996-11-12 Schering Corporation Tricyclic derivatives, compositions and methods of use
US5464840A (en) * 1993-12-06 1995-11-07 Schering Corporation Tricyclic derivatives, compositions and methods of use
US6524832B1 (en) * 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
ES2080700B1 (es) * 1994-07-27 1996-10-16 Farmihispania S A Nuevo procedimiento para la obtencion de loratadina.
ES2080699B1 (es) * 1994-07-27 1996-10-16 Farmahispania S A Nuevos derivados de 2-(1-etoxicarbonil-4-piperidiliden)metil)piridina y un procedimiento para su obtencion.
ES2087026B1 (es) * 1994-07-28 1997-03-16 Uriach & Cia Sa J Nuevo derivado de la benzo(5,6)ciclohepta- (1.2-b) piridina.
US5461057A (en) * 1994-09-08 1995-10-24 Schering Corporation Hydro-ethano-indeno-pyridines
US5684013A (en) * 1995-03-24 1997-11-04 Schering Corporation Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
US5700806A (en) * 1995-03-24 1997-12-23 Schering Corporation Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5712280A (en) * 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
US5891872A (en) * 1995-04-07 1999-04-06 Schering Corporation Tricyclic compounds
US5801175A (en) * 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5874442A (en) * 1995-12-22 1999-02-23 Schering-Plough Corporation Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease
PE92098A1 (es) * 1996-07-31 1998-12-31 Schering Corp N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo
CN1047774C (zh) * 1996-09-10 1999-12-29 上海华联制药有限公司 氮杂二苯并环庚烯酮类化合物的制备方法
US6071907A (en) * 1996-09-13 2000-06-06 Schering Corporation Tricyclic compounds useful as FPT inhibitors
US5958890A (en) * 1996-09-13 1999-09-28 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
ES2229340T3 (es) * 1996-09-13 2005-04-16 Schering Corporation Compuestos triciclicos antitumorales, inhibidores de farnesil-proteina-tranferasa.
US5861395A (en) * 1996-09-13 1999-01-19 Schering Corporation Compounds useful for inhibition of farnesyl proteins transferase
CN1104427C (zh) * 1996-09-13 2003-04-02 先灵公司 法呢基蛋白转移酶的三环抑制剂
US6030982A (en) * 1996-09-13 2000-02-29 Schering Corporationm Compounds useful for inhibition of farnesyl protein transferase
US5994364A (en) 1996-09-13 1999-11-30 Schering Corporation Tricyclic antitumor farnesyl protein transferase inhibitors
TR199901273T2 (xx) * 1996-09-13 1999-09-21 Schering Corporation Farnezil protein transferaz inhibisyonu i�in yararl� bile�ikler.
JP2001500515A (ja) * 1996-09-13 2001-01-16 シェーリング コーポレイション ファルネシルタンパク質トランスフェラーゼの阻害に有用な化合物
US5945429A (en) * 1996-09-13 1999-08-31 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5985879A (en) * 1996-09-13 1999-11-16 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6040305A (en) * 1996-09-13 2000-03-21 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6130229A (en) * 1996-10-09 2000-10-10 Schering Corporation Tricyclic compounds having activity as RAS-FPT inhibitors
US6239140B1 (en) 1997-06-17 2001-05-29 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6211193B1 (en) 1997-06-17 2001-04-03 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6218401B1 (en) 1997-06-17 2001-04-17 Schering Corporation Phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase
US6228865B1 (en) 1997-06-17 2001-05-08 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
WO1998057965A1 (en) * 1997-06-17 1998-12-23 Schering Corporation Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase
ATE222905T1 (de) * 1997-06-17 2002-09-15 Schering Corp Benzo(5,6)cyclohepta(1,2-b)pyridine derivate als farnesyl protein transferase inhibitoren
US6051582A (en) * 1997-06-17 2000-04-18 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US6689789B2 (en) 1997-06-17 2004-02-10 Schering Corporation Compounds useful for inhibition of farnesyl protein transferase
US5945430A (en) * 1997-06-17 1999-08-31 Schering Corporation Aminooxyamide tricyclic inhibitors of farnesyl-protein transferase
US5925639A (en) * 1997-06-17 1999-07-20 Schering Corporation Keto amide derivatives useful as farnesyl protein transferase inhibitors
NZ501617A (en) * 1997-06-17 2001-09-28 Schering Corp 4-(5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-piperidine derivatives useful for inhibition of farnesyl protein transferase
KR20010013944A (ko) * 1997-06-17 2001-02-26 둘락 노먼 씨. 파네실 단백질 트랜스퍼라제의 억제에 유용한벤조(5,6)사이클로헵타(1,2-b)피리딘 유도체
US6159984A (en) 1997-06-17 2000-12-12 Schering Corporation Farnesyl protein transferase inhibitors
CN1272844A (zh) * 1997-06-17 2000-11-08 先灵公司 作为法尼基蛋白转移酶抑制剂的苯并(5,6)芳庚并(1,2b)吡啶衍生物
US6576639B1 (en) 1997-06-17 2003-06-10 Schering Corporation Compounds for the inhibition of farnesyl protein transferase
US5925648A (en) * 1997-07-29 1999-07-20 Schering Corporation Tricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferase
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6686502B1 (en) 1999-03-26 2004-02-03 Ucb S.A. Compounds and methods for treatment of asthma, allergy and inflammatory disorders
PE20001566A1 (es) 1999-03-26 2001-02-05 Ucb Sa Piperazinas 1,4-sustituidas, piperidinas 1,4-sustituidas y 4-alquilidenilpiperidinas 1-sustituidas
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
US6455554B1 (en) 1999-06-07 2002-09-24 Targacept, Inc. Oxopyridinyl pharmaceutical compositions and methods for use
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
WO2004029039A1 (en) * 2002-09-24 2004-04-08 Morepen Laboratories Limited An improved process for the production of desloratadine
ES2232332T3 (es) * 2003-03-12 2007-08-16 Teva Pharmaceutical Industries Ltd Composiciones farmaceuticas estables de desloratadina.
CA2611530C (en) 2005-06-23 2012-11-20 Merck & Co., Inc. Tyrosine kinase inhibitors
US20070036859A1 (en) * 2005-08-11 2007-02-15 Perry Ronald L Sustained release antihistamine and decongestant composition
AU2006306496A1 (en) 2005-10-21 2007-05-03 Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
US20080287481A1 (en) * 2006-09-08 2008-11-20 Mayur Devjibhai Khunt Process for the preparation of desloratadine polymorph mixtures
CN103113348B (zh) * 2013-02-18 2015-03-25 扬子江药业集团江苏海慈生物药业有限公司 枸地氯雷他定的假多晶型及其制备方法
CN110818685A (zh) * 2019-10-08 2020-02-21 深圳市南山区人民医院 一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-异己基及其用途
CN110818684B (zh) * 2019-10-08 2023-04-07 深圳市南山区人民医院 一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-SH及其用途
CN110845473B (zh) * 2019-10-08 2023-04-07 深圳市南山区人民医院 一种抗金黄色葡萄球菌毒力和生物被膜形成的抑制剂Lo-乙酸乙酯及其用途
MX2022005102A (es) * 2019-10-31 2022-05-30 Jd Bioscience Inc Compuesto triciclico y uso farmaceutico del mismo.
CN115385892A (zh) * 2021-10-28 2022-11-25 天津市昕晨投资发展有限公司 地氯雷他定衍生物、其制备方法及其用途
CN115141229B (zh) * 2022-07-21 2023-12-12 华创合成制药股份有限公司 抗组胺类化合物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL132137C (fi) * 1963-04-24
US3419565A (en) * 1963-04-24 1968-12-31 Schering Corp Aza-dibenzocycloheptenes
US3409621A (en) * 1966-04-01 1968-11-05 Schering Corp Piperazino-aza-dibenzo-[a, d]-cycloheptenes
US3717647A (en) * 1971-04-09 1973-02-20 Schering Corp Alpha-nicotinoyl phenylacetonitriles
DE2640022A1 (de) * 1975-09-15 1977-03-24 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US4335036A (en) 1980-05-30 1982-06-15 E. I. Du Pont De Nemours And Company Plasticized polyvinyl butyral employing propylene oxide oligomers
US4282233B1 (en) * 1980-06-19 2000-09-05 Schering Corp Antihistaminic 11-(4-piperidylidene)-5h-benzoÄ5,6Ü-cyclohepta-Ä1,2Ü-pyridines
US4355036A (en) * 1980-06-19 1982-10-19 Schering Corporation Tricyclic-substituted piperidine antihistamines
HU194864B (en) * 1984-02-15 1988-03-28 Schering Corp Process for production of 8-chlor-6,11-dihydro-11-(4-piperidilidene)-5h-benzo (5,6)-cyclo-hepta (1,2-b) pyridine and its salts
DE3677842D1 (de) * 1985-05-13 1991-04-11 Schering Corp Verfahren zur herstellung von piperidyliden-dihydrodibenzo(a,d)zykloheptenen und deren azoderivate, so hergestellte verbindungen und ihre anwendung zur vorbereitung von heilmitteln.
US4804666A (en) * 1985-08-14 1989-02-14 Schering Corporation Antiallergic 6,11-dihydro-11-(4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines

Also Published As

Publication number Publication date
EP0330673A1 (en) 1989-09-06
MY102986A (en) 1993-03-31
KR930002489B1 (ko) 1993-04-02
OA09546A (en) 1993-01-31
IL84310A0 (en) 1988-03-31
DK73193D0 (da) 1993-06-21
IE872913L (en) 1988-04-30
AU604285B2 (en) 1990-12-13
AU8336287A (en) 1988-05-25
DE3750929D1 (de) 1995-02-09
ES2068179T3 (es) 1995-04-16
CA1321589C (en) 1993-08-24
JPH02500910A (ja) 1990-03-29
EP0685476A1 (en) 1995-12-06
FI96768B (fi) 1996-05-15
DE3750929T2 (de) 1995-06-01
SG44597A1 (en) 1997-12-19
ZA878128B (en) 1988-04-29
FI891806A (fi) 1989-04-17
FI96768C (fi) 1996-08-26
CA1305147C (en) 1992-07-14
PH26184A (en) 1992-03-18
DK73193A (da) 1993-06-21
ATE116310T1 (de) 1995-01-15
KR880701716A (ko) 1988-11-04
NZ222347A (en) 1990-03-27
WO1988003138A1 (en) 1988-05-05
US4826853A (en) 1989-05-02
EP0270818B1 (en) 1994-12-28
JPH0678316B2 (ja) 1994-10-05
IE65174B1 (en) 1995-10-04
EP0270818A1 (en) 1988-06-15
FI891806A0 (fi) 1989-04-17
CS414391A3 (en) 1992-09-16

Similar Documents

Publication Publication Date Title
US5151423B1 (en) Heterocyclic n-oxide derivatives of substituted benzo(5,6)cycloheptapyridines, compositions and methods of use
HK186396A (en) Benzo(5,6)cyclo-heptapyridines compositions and method of use
ZA904783B (en) 3,5,6-substituted derivatives of 1.2-o-isopropylidene-alpha-glucofuranose and intermediates for preparing these derivatives
KR950010075B1 (en) Process for the preparation of 1,2,3,6-tetrahydro-5-nitro-pyrimidine derivatives
IE872839L (en) Benzocycloheptapyridines
YU184988A (en) Process for obtaining derivatives of 4-amino-pyridine
ES8800679A1 (es) Un procedimiento para preparar derivados de piperiliden-dihidrodibenzo-(a,d)-cicloheptenos y derivados aza
EP0253468A3 (en) Six-membered heterocyclic derivatives of n'substituted-n,n'-diacylhydrazines
HUT45040A (en) Process for preparing 2,3-dihydrofuran derivatives
GB2216521B (en) Process for the preparation of 1,4-dihydro-pyridine derivatives
PH23992A (en) Optically active 2,3-dihydrobenzoxazine derivatives and process for preparing the same
PL266240A1 (en) Method of obtaining derivatives of 1,3,2-oxazaphosphorinate
HUT47109A (en) Process for producing 3-(acylaminomethyl)-5,6,7,8-tetrahydro-imidazo-(1,2-a)pyridine derivatives and pharmaceutical compositions comprising these compounds
PT86178A (en) Process for the preparation of benzo ]g" quinolines
PL287479A1 (en) Method of obtaining novel derivatives of 5,6-dimethyl-6-h-indolo (2,3-b) quinoline
PL287478A1 (en) Method of obtaining novel derivatives of 6-h-indolo-(2,3-b) quinoline
HU895806D0 (en) Process for the preparation of 17beta-hydroxy-pregna-4,9(11)-dien-3,20-dione derivatives
YU39287A (en) Process for preparation of derivatives 1,3 diazolyle-2-propanol
YU116389A (en) Process for preparing derivatives of 1,3-diazolyl-2-propanole

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)